Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Daniela Tartara"'
Autor:
Luigi Tommasi, Pamela Francesca Guglielmini, Alfredo Muni, maura vincenti, Vittorio Fusco, Daniela Tartara, Paola Brigo, Antonella Fasciolo
Background. Nuclear Medicine imaging techniques, i.e., planar bone scan (Tc99 m scintigraphy) and PET (Positron Emission Tomography) with several tracers, have been suggested as useful aids to diagnosis of Osteonecrosis of Jaw (ONJ), that is mostly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73aac97d0b59710d1d54676b1510b0f3
https://doi.org/10.32388/tuehci
https://doi.org/10.32388/tuehci
Autor:
Daniela Tartara, Paola Brigo, Vittorio Fusco, Elisabetta Ferrero, Carmela Riccio, Antonella Fasciolo
Osteonecrosis of the Jaw (ONJ) is a serious event, with negative consequences on the Quality of Life of advanced cancer and myeloma patients. Antiresorptive drugs (bisphosphonates and denosumab) are of great clinical benefit, they impose careful oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90698c35e98ac6b3f645948ca091af93
https://doi.org/10.32388/b2v21b
https://doi.org/10.32388/b2v21b
Autor:
Daniela Tartara, Vittorio Fusco, Antonella Fasciolo, Pamela Francesca Guglielmini, Maura Vincenti, Paola Brigo, Maura Rossi, Elisabetta Ferrero, Manuela Alessio, Iolanda De Martino, Carmela Riccio, Elena Traverso
Background. Osteonecrosis of the Jaw (ONJ) frequency after antiresorptive treatment in prostate cancer patients largely varied in literature. Patients and Methods. Charts of all prostate cancer patients affected by bone metastases observed at the Onc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b821432130c559023cf7b03a5070dce
https://doi.org/10.32388/g3baxg
https://doi.org/10.32388/g3baxg
Autor:
Vittorio Fusco, Anna Baraldi, Daniela Tartara, Federico Monaco, Elisabetta Ferrero, M Ladetto, Gioacchino Catania, Antonella Fasciolo, Paola Brigo, Giulia Limberti
Background. Expected survival of myeloma patients increased in recent decades, after introduction of new drugs and strategies. Median survival has been reported about 5 years, but it is very variable, according to age, comorbidities, disease stage, e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27887f351ef668049fd463fcc47583b3
https://doi.org/10.32388/ztqigk
https://doi.org/10.32388/ztqigk
Autor:
Manuela Alessio, Daniela Tartara, Elisabetta Ferrero, Pier Luigi Piovano, Carmela Riccio, maura vincenti, Pamela Guglielmini, Vittorio Fusco, Maura Rossi, Iolanda De Martino, Antonella Fasciolo, Paola Brigo
Background. Osteonecrosis of the Jaw (ONJ) frequency after antiresorptive treatment in prostate cancer patients largely varied in literature. Patients and Methods. Charts of all prostate cancer patients affected by bone metastases observed at the Onc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6333dfde386297645a6eba0f23523c9
https://doi.org/10.32388/xzi27k
https://doi.org/10.32388/xzi27k
Autor:
Giulia Limberti, Elisabetta Ferrero, Vittorio Fusco, Paola Brigo, Anna Baraldi, Gioacchino Catania, M Ladetto, Antonella Fasciolo, Daniela Tartara
Charts of all myeloma patients observed at the Hematology Unit of Alessandria Hospital (Italy) in years 2005-2020 have been reviewed. Patients received bisphosphonates according to international guidelines, that recommended shorter and tailored durat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40173ff9db649d328bee3ceaf30ca0ba
https://doi.org/10.32388/r0tl9y
https://doi.org/10.32388/r0tl9y
Autor:
Iolanda De Martino, Paola Brigo, Daniela Tartara, Manuela Alessio, Riccardo Alberto Campora, Vittorio Fusco, Antonella Fasciolo, Maura Rossi
PATIENTS AT RISK OF OSTEONECROSIS OF THE JAW (ONJ) INCLUDE MOSTLY CANCER AND MYELOMA PATIENTS RECEIVING ANTIRESORPTIVE TREATMENTS (BISPHOSPHONATES AND DENOSUMAB) WITH/WITHOUT BIOLOGICAL AGENTS, BUT ALSO PATIENTS WITH OSTEOPOROSIS AND RHEUMATOLOGIC DI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcd2e44ae4e76b5d02e6dcad05865907
https://doi.org/10.32388/0qk8e2
https://doi.org/10.32388/0qk8e2
Autor:
L. Benzi, Vittorio Fusco, Daniela Tartara, Manuela Alessio, R. Gaino, M. Rapetti, R. Cammarata, E. Caravaggio, maura vincenti, I. De Martino, P. Gugliemini, Antonella Fasciolo
Publikováno v:
Annals of Oncology. 26:vi117
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b60adeac5239175249d839f98bedc2aa
https://doi.org/10.1093/annonc/mdv346.15
https://doi.org/10.1093/annonc/mdv346.15
